224 related articles for article (PubMed ID: 15051724)
1. Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.
Marchesini N; Osta W; Bielawski J; Luberto C; Obeid LM; Hannun YA
J Biol Chem; 2004 Jun; 279(24):25101-11. PubMed ID: 15051724
[TBL] [Abstract][Full Text] [Related]
2. Confluence induced threonine41/serine45 phospho-beta-catenin dephosphorylation via ceramide-mediated activation of PP1cgamma.
Marchesini N; Jones JA; Hannun YA
Biochim Biophys Acta; 2007 Dec; 1771(12):1418-28. PubMed ID: 17996206
[TBL] [Abstract][Full Text] [Related]
3. Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase.
Clarke CJ; Mediwala K; Jenkins RW; Sutton CA; Tholanikunnel BG; Hannun YA
J Biol Chem; 2011 Jun; 286(24):21565-76. PubMed ID: 21536668
[TBL] [Abstract][Full Text] [Related]
4. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
Marchesini N; Luberto C; Hannun YA
J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
[TBL] [Abstract][Full Text] [Related]
5. Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells.
Clarke CJ; Cloessner EA; Roddy PL; Hannun YA
Biochem J; 2011 Apr; 435(2):381-90. PubMed ID: 21303347
[TBL] [Abstract][Full Text] [Related]
6. P53-dependent upregulation of neutral sphingomyelinase-2: role in doxorubicin-induced growth arrest.
Shamseddine AA; Clarke CJ; Carroll B; Airola MV; Mohammed S; Rella A; Obeid LM; Hannun YA
Cell Death Dis; 2015 Oct; 6(10):e1947. PubMed ID: 26512957
[TBL] [Abstract][Full Text] [Related]
7. Interaction of Synaptosomal-Associated Protein 25 with Neutral Sphingomyelinase 2: Functional Impact on the Sphingomyelin Pathway.
Won JH; Jeon HJ; Kim SK; Shin IC; Jang JM; Ha HC; Back MJ; Kim DK
Neuroscience; 2020 Feb; 427():1-15. PubMed ID: 31765623
[TBL] [Abstract][Full Text] [Related]
8. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.
Figuera-Losada M; Stathis M; Dorskind JM; Thomas AG; Bandaru VV; Yoo SW; Westwood NJ; Rogers GW; McArthur JC; Haughey NJ; Slusher BS; Rojas C
PLoS One; 2015; 10(5):e0124481. PubMed ID: 26010541
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin.
Ito H; Murakami M; Furuhata A; Gao S; Yoshida K; Sobue S; Hagiwara K; Takagi A; Kojima T; Suzuki M; Banno Y; Tanaka K; Tamiya-Koizumi K; Kyogashima M; Nozawa Y; Murate T
Biochim Biophys Acta; 2009; 1789(11-12):681-90. PubMed ID: 19698806
[TBL] [Abstract][Full Text] [Related]
10. Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium.
Kim SK; Ahn KH; Ji JE; Choi JM; Jeon HJ; Jung SY; Jung KM; Kim DK
Cell Signal; 2010 May; 22(5):865-70. PubMed ID: 20096352
[TBL] [Abstract][Full Text] [Related]
11. Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells.
Clarke CJ; Guthrie JM; Hannun YA
Mol Pharmacol; 2008 Oct; 74(4):1022-32. PubMed ID: 18653803
[TBL] [Abstract][Full Text] [Related]
12. [Advance in research on regulatory mechanism and functions of neutral sphingomyelinse 2].
Zhang L; Guo J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Oct; 35(5):581-5. PubMed ID: 24183051
[TBL] [Abstract][Full Text] [Related]
13. Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression.
Phillips DC; Hunt JT; Moneypenny CG; Maclean KH; McKenzie PP; Harris LC; Houghton JA
Cell Death Differ; 2007 Oct; 14(10):1780-91. PubMed ID: 17627285
[TBL] [Abstract][Full Text] [Related]
14. Regulated translocation of neutral sphingomyelinase-2 to the plasma membrane drives insulin resistance in steatotic hepatocytes.
El-Amouri S; Karakashian A; Bieberich E; Nikolova-Karakashian M
J Lipid Res; 2023 Oct; 64(10):100435. PubMed ID: 37640282
[TBL] [Abstract][Full Text] [Related]
15. Src regulates cigarette smoke-induced ceramide generation via neutral sphingomyelinase 2 in the airway epithelium.
Chung S; Vu S; Filosto S; Goldkorn T
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):738-48. PubMed ID: 25347576
[TBL] [Abstract][Full Text] [Related]
16. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi.
Gu L; Huang B; Shen W; Gao L; Ding Z; Wu H; Guo J
J Neuroinflammation; 2013 Sep; 10():109. PubMed ID: 24007266
[TBL] [Abstract][Full Text] [Related]
17. Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M.
Lee JY; Leonhardt LG; Obeid LM
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):457-61. PubMed ID: 9716505
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.
Wu BX; Zeidan YH; Hannun YA
Biochim Biophys Acta; 2009 Aug; 1791(8):730-9. PubMed ID: 19345744
[TBL] [Abstract][Full Text] [Related]
19. Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide induction.
Meyers-Needham M; Lewis JA; Gencer S; Sentelle RD; Saddoughi SA; Clarke CJ; Hannun YA; Norell H; da Palma TM; Nishimura M; Kraveka JM; Khavandgar Z; Murshed M; Cevik MO; Ogretmen B
Mol Cancer Ther; 2012 May; 11(5):1092-102. PubMed ID: 22452947
[TBL] [Abstract][Full Text] [Related]
20. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
